Achondroplasia, the most common form of skeletal dysplasia, is a rare genetic condition caused by gain-of-function variation to a gene that plays a key role in developing and maintaining bones. This results in reduced endochondral bone growth and short stature.

Learn more about our active achondroplasia clinical trials below. To view all BioMarin’s historical trials in achondroplasia, click here.